082850.KQ
Wooree Bio Co.,Ltd
KOSDAQKRWEQUITY
DELAYED
Last price
897.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
897.00
Day high
897.00
Day low
897.00
Volume
0
Market cap
$42.35B
P/E (TTM)
—
52W range
712.00 – 2,675.00
Trailing performance
Returnvs SPY
1W
0.00%
+1.2%
1M
-17.48%
-20.8%
3M
-52.44%
-54.8%
6M
-52.96%
-64.8%
YTD
-55.92%
-67.9%
1Y
-61.34%
-81.5%
3Y
-61.00%
-136.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 082850.KQ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap$42.35B
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.04T | $1.24T | $1.26T | $1.36T | -15.6% |
| Operating revenue | $1.04T | $1.24T | $1.26T | $1.36T | -15.6% |
| Cost of revenue | $948.81B | $1.12T | $1.15T | $1.24T | -15.2% |
| Gross profit | $95.15B | $118.80B | $116.35B | $114.57B | -19.9% |
| Research & development | $11.11B | $11.44B | $8.40B | $7.02B | -2.9% |
| Selling, general & admin | $40.62B | $50.96B | $43.87B | $35.02B | -20.3% |
| Total operating expense | $94.20B | $103.59B | $89.49B | $79.87B | -9.1% |
| Operating income | $958.16M | $15.22B | $26.85B | $34.71B | -93.7% |
| Net interest income | -$2.74B | -$1.12B | -$2.26B | -$3.44B | -145.3% |
| Pre-tax income | -$6.36B | $24.54B | $21.73B | $32.03B | -125.9% |
| Tax provision | $3.82B | $16.31B | $2.78B | $6.90B | -76.6% |
| Net income | -$9.37B | $4.74B | $15.58B | $21.82B | -297.6% |
| Net income to common | -$9.37B | $4.74B | $15.58B | $21.82B | -297.6% |
| Basic EPS | -199.00 | 100.00 | 331.00 | 469.00 | -299.0% |
| Diluted EPS | -199.00 | 100.00 | 329.00 | 469.00 | -299.0% |
| EBIT | -$230.07M | $29.94B | $27.78B | $36.97B | -100.8% |
| EBITDA | $27.44B | $57.47B | $59.63B | $73.17B | -52.3% |
| Basic shares | 47.11M | 47.43M | 47.07M | 46.53M | -0.7% |
| Diluted shares | 47.11M | 47.43M | 47.36M | 46.53M | -0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $107.03B | $69.48B | $60.21B | $66.08B | +54.0% |
| Cash & short-term investments | $130.80B | $108.17B | $123.74B | $132.52B | +20.9% |
| Accounts receivable | $299.47B | $163.63B | $215.09B | $162.91B | +83.0% |
| Inventory | $78.81B | $104.60B | $95.62B | $96.82B | -24.7% |
| Total current assets | $568.80B | $405.20B | $452.66B | $412.97B | +40.4% |
| Property, plant & equipment | $174.27B | $186.67B | $114.20B | $124.92B | -6.6% |
| Goodwill & intangibles | $2.62B | $3.11B | $3.36B | $3.88B | -16.0% |
| Total assets | $761.92B | $609.82B | $585.54B | $558.94B | +24.9% |
| Total current liabilities | $451.25B | $280.79B | $317.14B | $304.31B | +60.7% |
| Current debt | $74.25B | $59.01B | $63.68B | $76.53B | +25.8% |
| Long-term debt | $42.35B | $45.05B | $256.08M | $7.66B | -6.0% |
| Total debt | $127.98B | $122.13B | $85.13B | $108.52B | +4.8% |
| Total liabilities | $500.57B | $340.61B | $334.44B | $332.21B | +47.0% |
| Retained earnings | $72.02B | $53.61B | $50.09B | $35.12B | +34.3% |
| Shareholder equity | $204.75B | $212.13B | $199.47B | $179.01B | -3.5% |
| Working capital | $117.54B | $124.41B | $135.52B | $108.67B | -5.5% |
| Net tangible assets | $202.13B | $209.02B | $196.10B | $175.14B | -3.3% |
| Shares issued | 47.21M | 48.46M | 48.44M | 48.00M | -2.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$10.17B | $8.23B | $18.95B | $25.13B | -223.7% |
| Depreciation & amortisation | $27.67B | $27.53B | $31.85B | $36.19B | +0.5% |
| Stock-based compensation | $274.70M | $111.89M | $364.55M | $400.24M | +145.5% |
| Change in working capital | $19.33B | -$1.98B | -$22.56B | -$31.47B | +1,075.2% |
| Operating cash flow | $34.82B | $36.24B | $26.51B | $43.35B | -3.9% |
| Capital expenditure | -$22.42B | -$83.57B | -$11.07B | -$13.42B | +73.2% |
| Investing cash flow | -$1.22B | -$54.06B | -$5.50B | -$42.45B | +97.7% |
| Financing cash flow | $3.65B | $26.71B | -$29.35B | -$21.28B | -86.3% |
| Free cash flow | $12.41B | -$47.33B | $15.45B | $29.93B | +126.2% |
| End cash position | $107.03B | $69.48B | $60.21B | $66.08B | +54.0% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $269.20B | $250.75B | $263.90B | $231.01B | $298.30B | +7.4% |
| Operating revenue | $269.20B | $250.75B | $263.90B | $231.01B | $298.30B | +7.4% |
| Cost of revenue | $245.65B | $229.33B | $237.72B | $207.67B | $274.08B | +7.1% |
| Gross profit | $23.55B | $21.43B | $26.18B | $23.33B | $24.22B | +9.9% |
| Research & development | $2.73B | $2.94B | $2.44B | $2.72B | $3.02B | -7.2% |
| Selling, general & admin | $13.11B | $8.07B | $10.39B | $12.79B | $9.37B | +62.4% |
| Total operating expense | $27.86B | $21.27B | $23.81B | $25.68B | $23.44B | +31.0% |
| Operating income | -$4.31B | $153.76M | $2.37B | -$2.34B | $776.86M | -2,905.4% |
| Net interest income | -$689.14M | -$564.00M | -$346.02M | -$646.30M | -$1.18B | -22.2% |
| Pre-tax income | $1.35B | -$1.51B | $5.59B | -$10.24B | -$189.62M | +188.9% |
| Tax provision | $994.41M | $594.12M | $2.88B | $965.78K | $338.55M | +67.4% |
| Net income | $2.18B | -$977.14M | $2.48B | -$10.35B | -$521.04M | +322.6% |
| Net income to common | $2.18B | -$977.14M | $2.48B | -$10.35B | -$521.04M | +322.6% |
| Basic EPS | 46.00 | — | 52.00 | -219.00 | -11.00 | — |
| Diluted EPS | 46.00 | — | 52.00 | -219.00 | -11.00 | — |
| EBIT | $2.69B | -$102.93M | $6.82B | -$8.63B | $1.68B | +2,716.7% |
| EBITDA | $9.43B | $6.97B | $13.61B | -$1.72B | $8.58B | +35.2% |
| Basic shares | 47.21M | — | 47.21M | 47.21M | 47.37M | — |
| Diluted shares | 47.21M | — | 47.21M | 47.21M | 47.37M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $141.29B | $107.03B | $89.04B | $111.60B | $57.22B | +32.0% |
| Cash & short-term investments | $161.39B | $130.80B | $117.83B | $131.83B | $91.12B | +23.4% |
| Accounts receivable | $354.29B | $299.47B | $328.22B | $274.78B | $358.52B | +18.3% |
| Inventory | $86.82B | $78.81B | $85.53B | $85.34B | $137.05B | +10.2% |
| Total current assets | $667.93B | $568.80B | $589.26B | $556.89B | $642.31B | +17.4% |
| Property, plant & equipment | $175.55B | $174.27B | $175.76B | $173.50B | $183.42B | +0.7% |
| Goodwill & intangibles | $2.85B | $2.62B | $3.10B | $3.07B | $3.19B | +9.1% |
| Total assets | $868.22B | $761.92B | $782.08B | $747.33B | $843.47B | +14.0% |
| Total current liabilities | $550.92B | $451.25B | $471.59B | $444.66B | $518.60B | +22.1% |
| Current debt | $78.58B | $74.25B | $72.59B | $64.44B | $66.65B | +5.8% |
| Long-term debt | $44.45B | $42.35B | $39.99B | $38.69B | $45.67B | +4.9% |
| Total debt | $133.42B | $127.98B | $125.56B | $117.34B | $129.50B | +4.3% |
| Total liabilities | $602.31B | $500.57B | $522.60B | $494.65B | $577.23B | +20.3% |
| Retained earnings | $73.24B | $72.02B | $71.25B | $68.79B | $79.15B | +1.7% |
| Shareholder equity | $211.06B | $204.75B | $204.25B | $196.00B | $209.10B | +3.1% |
| Working capital | $117.01B | $117.54B | $117.67B | $112.23B | $123.71B | -0.5% |
| Net tangible assets | $208.20B | $202.13B | $201.16B | $192.94B | $205.90B | +3.0% |
| Shares issued | 48.46M | 47.21M | 48.46M | 48.46M | 48.46M | +2.6% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $350.88M | -$2.11B | $2.71B | -$10.24B | -$528.17M | +116.7% |
| Depreciation & amortisation | $6.73B | $7.08B | $6.78B | $6.91B | $6.90B | -4.9% |
| Stock-based compensation | $91.62M | $99.29M | $99.29M | $71.23M | $4.89M | -7.7% |
| Change in working capital | $29.72B | $8.92B | -$17.69B | $56.28B | -$28.19B | +233.1% |
| Operating cash flow | $33.98B | $14.99B | -$18.11B | $59.39B | -$21.45B | +126.7% |
| Capital expenditure | -$3.07B | -$6.82B | -$4.54B | -$8.08B | -$2.98B | +55.1% |
| Investing cash flow | -$4.41B | $1.59B | -$12.26B | $5.97B | $3.49B | -378.5% |
| Financing cash flow | $475.59M | -$338.02M | $5.49B | -$8.01B | $6.52B | +240.7% |
| Free cash flow | $30.92B | $8.17B | -$22.66B | $51.32B | -$24.42B | +278.6% |
| End cash position | $141.29B | $107.03B | $89.04B | $111.60B | $57.22B | +32.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
907.90
-1.20% from price
SMA 20
925.05
-3.03% from price
SMA 50
1,067.06
-15.94% from price
SMA 100
1,490.63
-39.82% from price
SMA 200
1,740.65
-48.47% from price
EMA 12
914.52
-1.92% from price
EMA 26
972.44
-7.76% from price
EMA 50
1,111.72
-19.31% from price
RSI (14)
34.8
Neutral
MACD (12,26,9)
-57.92
Hist 9.76
ATR (14)
24.07
2.68% of price
Realised vol 30D
65.9%
Annualised
Bollinger upper
1,019.96
20, 2σ
Bollinger lower
830.14
20, 2σ
50 / 200 cross
Death
1,067.06 vs 1,740.65
Trend bias
Below 200
-48.47%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.08
Less volatile than market
Correlation to SPY
0.02
Largely independent
Realised vol 30D
65.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-65.2%
Peak to trough
Max drawdown 5Y
-85.3%
Peak to trough
ATR 14
24.07
2.68% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Toronto Author and Professional Golfer Stacey Soans Launches Fairways & Femininity, Exploring the Connection Between Golf and Leadership
TMX Newsfile · 4m ago
Mini PC Brand VZMORE Makes Global Debut at ShowStoppers @ IFA 2026, Bringing Advanced Thermal Innovation to Mini PCs
PR Newswire · 7m ago
Zodiac Partners II, LLC Announces Final Results of its Tender Offer
GlobeNewswire · 9m ago
United Bankshares: An Underrated Dividend Stock with a 52-Year Growth Streak
Insider Monkey · 14m ago
Woodside Energy Group H1 Earnings Call Highlights
MarketBeat · 20m ago
Tuya Q2 Earnings Call Highlights
MarketBeat · 20m ago
Wolters Kluwer and Dentsu Soken Deliver CCH® Tagetik as Daihatsu Motor’s Budget Management System
Business Wire · 22m ago
Henox and Nexusguard Announce Strategic Alliance at BATIC 2026 to Power and Protect the Next Generation of Digital Infrastructure
PR Newswire · 22m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.